Shanghai CASB Biotechnology Co.,LTD

Shanghai CASB Biotechnology Co., Ltd. (CASB), which is formerly an pure academic institute-Shanghai Research Center of Biotechnology (SRCB) before the Knowledge Innovation Programme (KIP) of Chinese Academy of Science(CAS)，is located in Caohejing High-Tech Developing Zone and Biological High-Tech Incubator Park of Xuhui District. Shanghai Institutes of Biological Sciences (SIBS) of CAS and other 29 natural persons share the holders of the Corporate. Arising from academic institution, CASB has powerful strength in R&D and commercialization. It is equipped with pilot manufacture basements for genetic engineering and fermentation, also the supporting facilities for waste transportation and lab animals house, some advanced apparatus for pilot research. There are nearly 40 professionals with senior and intermedium titles, among which a member of Chinese Academy of Engineering (CAE)and 4 mentors for Ph.D graduate students are engaged. The company can also award master degrees. CASB has a couple of leading scientists in such research fields as genetic engineering, fermentation, biochemical engineering, protein engineering, microbiology and laboratory animals. For the long time CASB has accumulated a lot of experimental technologies and experience and acquired several achievements and patents including “pilot study of production of K88 and K99”, “recombinant human TNF mutant”, “recombinant hemoglobin”, “recombinant fish growth hormone”. CASB also got many papers published in prestigious journals. And currently, it is still in charge of over 10 projects funded by the state and ministries and a framework including both applied research and pilot study has been formed. CASB affords R&D basis for commercialization and industrialization of technology and is trying to find a way to connect market economy with Chinese characteristics and internationalization. CASB is established in the light of modern enterprises and has clear ownership and perfect structure of juridical person. Six sections such as logistics, R&D, market,, finance, manufacture and sales.operate well under the leadership of general manager. CASB also holds shares of “Shanghai Yuandong Biotech Co. Ltd.”, “Shanghai CAS Co. Ltd.”, “Shanghai Pioneer S&T Co.”, and “Shanghai Pioneer Investment Co.”, which create satisfying market performance at home and abroad for high quality products. CASB aims to become a high-tech group in biotech fields finally. It will take full advantage of R&D power, activate both tangible and non-tangible assets, exploit potential of itself, expand cooperation in diversified operations, develop new products and technological platforms, strengthen the collection of market information and train R&D team, accelerate the transformation from technology to products as soon as possible.